This treatment regimen has been shown to improve recurrence-free survival, or RFS, and overall survival, or OS, for KIT+ GIST patients compared to 12 months of treatment. The US approval was based on...
KALYDECO is approved for people with CF ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was granted...
The company has also announced the assignment of US co-promotion rights to AQUORAL, an FDA-cleared, prescription-only spray for the treatment of Xerostomia, or the medical term for dry mouth due to a lack...
M2 BEST BOOKS-(C)2000-2012 M2 COMMUNICATIONS The Association of Flight Attendants-CWA (AFA) on Monday said that its president Veda Shook has taken part in the official announcement of the implementation of the Airline Flight...
In SHARP, VYTORIN 10/20 mg lowered LDL cholesterol in patients with moderate to severe chronic kidney disease, or CKD, and major vascular events were reduced in the treatment group compared to placebo. The...
AIRLINE INDUSTRY INFORMATION-(C)1997-2012 M2 COMMUNICATIONS The Association of Flight Attendants-CWA (AFA) on Monday said that its president Veda Shook has taken part in the official announcement of the implementation of the Airline Flight...
Health care reform is projected to cover 30 million more people, with health insurance--and overwhelm the nation's doctors. That's where Walgreen Co. thinks. it can help. Executives of the Illinois-based company, including its...
Keppra was previously approved in the US as adjunctive therapy for partial onset seizures in adults and children four years of age and older with epilepsy. The approval was based on data from...
As many employers are aware, the Patient Protection and Affordable Care Act amends the Internal Revenue Code to require employers to report the aggregate cost of applicable employer-sponsored health coverage on employees' W-2...
Colorado's hospitals are expecting a legislative session with few health care bills -- but that doesn't mean they don't have some concerns. Rep. Marsha Looper has filed a bill that seeks to repeal...
Results from the trial, expected in 2014, could potentially impact atrial fibrillation treatment guidelines by providing further clinical evidence regarding the benefits of the Arctic Front system in treating a largely underserved patient...
GS-7340 is a novel prodrug of tenofovir, the active agent in Viread, or tenofovir disoproxil fumarate. In previous studies, GS-7340 has demonstrated the ability to provide greater antiviral efficacy at a dose that...
For overweight consumers looking to lose weight fast, the use of lap band surgery as a quick and easy way to a new life can be tempting. But in some cases, it's deadly....
Steven P. Block Partner Futterman, Lanza & Block An attorney and a certified public accountant, Block advises clients on all aspects of estate and elder law planning. In 2011, he merged his practice...
An independent watchdog group has asked the Food and Drug Administration to disregard a safety panel's recommendation to keep the popular birth control drugs Yaz and Yasmin on the market, citing evidence that...
As a result of the positive interim analysis, the FAME II independent Data Safety Monitoring Board, or DSMB, has recommended investigators stop patient enrollment in this trial as the DSMB considers it unethical...
A local health care group has created a Web page to spread the word about what health care reform means to you. The Nassau-Suffolk Hospital Campaign has created a Web page with links...
The Medicines Company (MDCO) has settled the lawsuits filed in the US district court for the district of Delaware relating to the Abbreviated New Drug Application (ANDA) filed by APP Pharmaceuticals, LLC (APP)...
NovaDel Pharma, Inc., a specialty pharmaceutical company, has terminated its license agreements with Talon Therapeutics, Inc. (formerly Hana Biosciences, Inc. ) and Par Pharmaceutical Companies, Inc., for Zensana. Talon is a biopharmaceutical company,...
After a long delay, Roche Diagnostics Corp. this month won approval from the U.S. Food and Drug Administration for its Accu-Chek Nano SmartView blood glucose monitoring system. The approval comes more than two...